Dagmar Rosa-Bjorkeson's Net Worth
$1.15 Million
Who is Dagmar Rosa-Bjorkeson?
Dagmar Rosa-Bjorkeson has an estimated net worth of $1.15 Million. This is based on reported shares across multiple companies, which include INTERCEPT PHARMACEUTICALS, INC., Xencor Inc, Mallinckrodt plc, and Baxalta Inc.
SEC CIK
Dagmar Rosa-Bjorkeson's CIK is 0001643934
Past Insider Trading and Trends
2015 was Dagmar Rosa-Bjorkeson's most active year for acquiring shares with 4 total transactions. Dagmar Rosa-Bjorkeson's most active month to acquire stocks was the month of April. 2023 was Dagmar Rosa-Bjorkeson's most active year for disposing of shares, totalling 5 transactions. Dagmar Rosa-Bjorkeson's most active month to dispose stocks was the month of May. 2015 saw Dagmar Rosa-Bjorkeson paying a total of $0.00 for 204,191 shares, this is the most they've acquired in one year. In 2023 Dagmar Rosa-Bjorkeson cashed out on 69,447 shares for a total of $501,429.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
INTERCEPT PHARMACEUTICALS, INC. (ICPT) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -26.39K |
$19.00 | -$501,429.00 |
0
|
Nov 8
| |||
Form 4
| +44.37% | 8.11K |
—
|
—
| 26.39K |
May 24
| |||
Form 4
| +73.39% | 7.74K |
—
|
—
| 18.28K |
May 25
| |||
Form 4
|
∞
| 10.54K |
—
|
—
| 10.54K |
May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xencor Inc (XNCR) Snapshot price: $19.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +119.55% | 5.99K |
—
|
—
| 10.99K |
Jun 13
| |||
Form 4
|
∞
| 5.01K |
—
|
—
| 5.01K |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Mallinckrodt plc (MNKTQ) Snapshot price: $0.12
Chief Strat & Corp Dev Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.04% | -246.00 |
$9.06 | -$2,228.76 | 23.43K |
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
| +41.47% | 6.58K |
$22.80 | -$24,236.40 | 22.43K |
Apr 1 - Apr 2
| |||
Form 4
| -1.53% | -247.00 |
$17.05 | -$4,211.35 | 15.85K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Baxalta Inc No price found
EVP and President, Biosimilars
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -71.29K |
—
|
—
|
0
|
Jun 3
| |||
Form 4
| +25.11% | 14.28K |
$39.30 | -$38,592.60 | 71.14K |
Mar 3
| |||
Form 4/A
| -10.83% | -6.89K |
$34.63 | -$238,704.59 | 56.74K |
Dec 1
| |||
Form 4
| -37.25% | -6.89K |
$34.63 | -$238,704.59 | 11.61K |
Dec 1
| |||
Form 4
|
∞
| 62.97K |
—
|
—
| 62.97K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||